Skip to main content
Smart Investors Daily
VE

NASDAQ · VERO

Venus Concept Inc.

Healthcare · Medical - Devices

$0.31

Up+$0.01 (+2.64%)

Updated Sep 13, 2026, 7:28 PM

SID Score

4.3/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
3.47M
P/E ratio
-0.06
Dividend yield
0.00%
52-week range
— – —
Volume
43
Avg. volume
633.97K

Price performance

VERO price history

1M range · 0 trading sessions · Daily adjusted prices

VERO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VERO news

The latest Smart Investors Daily articles mentioning VERO.

VERO research

Overview

Company profile and research snapshot.

Company profile

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$10.81
Implied upside
Analysts
7
VERO recent ratings
DateFirmRatingTarget
Oct 6, 2023BTIGNeutral
Mar 28, 2023Ladenburg ThalmannBuy
Mar 28, 2023Maxim GroupHold
Jun 24, 2022BTIGBuy
Dec 9, 2020StifelHold
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 13, 2025

Venus Concept: Q3 Earnings Snapshot

TORONTO (AP) — Venus Concept Inc. VERO) on Thursday reported a loss of $22.6 million in its third quarter. The Toronto-based company said it had a loss of $12.14 per share.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.